Lincoln National Corp Ionis Pharmaceuticals Inc Transaction History

Lincoln National Corp

$3.11 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$33.58 - $41.2 $2,182 - $2,678	-65 Reduced 0.5%	13,034 $465,000
Q4 2022 Feb 07, 2023	BUY	$37.12 - $46.52 $9,985 - $12,513	269 Added 2.1%	13,099 $494,000
Q3 2022 Nov 03, 2022	SELL	$36.54 - $48.66 $15,748 - $20,972	-431 Reduced 3.25%	12,830 $567,000
Q1 2022 May 09, 2022	SELL	$29.88 - $37.04 $24,172 - $29,965	-809 Reduced 5.75%	13,261 $491,000
Q4 2021 Jan 26, 2022	SELL	$25.61 - $35.1 $5,122 - $7,020	-200 Reduced 1.4%	14,070 $428,000
Q3 2021 Nov 05, 2021	SELL	$33.54 - $40.55 $26,832 - $32,439	-800 Reduced 5.31%	14,270 $479,000
Q2 2021 Aug 13, 2021	SELL	$34.54 - $47.25 $13,643 - $18,663	-395 Reduced 2.55%	15,070 $601,000
Q1 2021 May 10, 2021	SELL	$42.51 - $63.78 $69,716 - $104,599	-1,640 Reduced 9.59%	15,465 $695,000
Q3 2020 Nov 09, 2020	SELL	$47.45 - $62.95 $10,059 - $13,345	-212 Reduced 1.22%	17,105 $812,000
Q2 2020 Jul 31, 2020	SELL	$46.85 - $61.05 $11,946 - $15,567	-255 Reduced 1.45%	17,317 $1.02 Million
Q1 2020 Apr 24, 2020	SELL	$41.6 - $63.4 $37,523 - $57,186	-902 Reduced 4.88%	17,572 $831,000
Q4 2019 Feb 07, 2020	BUY	$53.85 - $65.27 $26,925 - $32,634	500 Added 2.78%	18,474 $1.12 Million
Q3 2019 Nov 06, 2019	BUY	$59.06 - $72.15 $32,069 - $39,177	543 Added 3.12%	17,974 $1.08 Million
Q2 2019 Aug 06, 2019	SELL	$62.09 - $86.14 $110,954 - $153,932	-1,787 Reduced 9.3%	17,431 $1.12 Million
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $113,090 - $173,460	2,137 Added 12.51%	19,218 $1.56 Million
Q4 2018 Feb 08, 2019	SELL	$43.37 - $59.54 $89,342 - $122,652	-2,060 Reduced 10.76%	17,081 $923,000
Q3 2018 Nov 06, 2018	BUY	$42.88 - $53.7 $126,881 - $158,898	2,959 Added 18.29%	19,141 $987,000
Q2 2018 Aug 08, 2018	BUY	$40.53 - $50.7 $146,313 - $183,027	3,610 Added 28.71%	16,182 $674,000
Q1 2018 May 09, 2018	SELL	$44.08 - $55.05 $557,259 - $695,942	-12,642 Reduced 50.14%	12,572 $554,000
Q4 2017 Feb 13, 2018	BUY	$50.3 - $64.39 $1.01 Million - $1.3 Million	20,162 Added 399.09%	25,214 $1.27 Million
Q3 2017 Oct 31, 2017	BUY	$45.56 - $59.57 $230,169 - $300,947	5,052	5,052 $256,000

Others Institutions Holding IONS

# of Institutions

403

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$567 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$534 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$389 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$329 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$297 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.

Account